8
Views
1
CrossRef citations to date
0
Altmetric
DRUG WITHDRAWAL

Adverse effects of sudden withdrawal of antihypertensive medication

Pages 129-140 | Published online: 07 Jul 2016

References

  • Garbus SB, Weber MA, Priest RT, et al. The abrupt discontinuation of antihypertensive treatment. J Clin Pharmacol 1979; 19: 476–86
  • Strauss FC, Franklin SS, Lewin AJ, et al. Withdrawal of antihypertensive therapy: hypertensive crisis in renovascular hypertension. JAMA 1977; 238: 1734–6
  • Brodsky JB, Bravo JJ. Acute postoperative Clonidine withdrawal syndrome. Anesthesiology 1976; 44: 519–20
  • Bailey RR, Neale TJ. Rapid Clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade. Br Med J 1976; 1: 942–3
  • Reid JL, Wing LM, Dargie HJ, et al. Clonidine withdrawal in hypertension: changes in blood-pressure and plasma and urinary noradrenalin. Lancet 1977; 1: 1171–4
  • Hoobler SW, Kashima T. Central nervous system actions of Clonidine in hypertension. Mayo Clin Proc 1977; 52: 395–8
  • Whitsett TL, Chrysant SG, Dillard BL, et al. Abrupt cessation of Clonidine administration: a prospective study. Am J Cardiol 1978; 41: 1285–90
  • Anderson RJ, Ram CV, Kaplan NM. Abrupt discontinuation of Clonidine therapy: monitoring the blood pressure changes in outpatients with a semi-automatic blood pressure recording device. Clin Res 1979: 27: 311A
  • Cannon PJ, Whitlock RT, Morris RC, et al. Effect of alpha-methyl DOPA in severe and malignant hypertension. JAMA 1962; 179: 673–81
  • Horwitz D, Pettinger WA, Orvis H, et al. Effects of methyldopa in fifty hypertensive patients. Clin Pharmacol Ther 1967: 8: 224–34
  • Burden AC, Alexander CP. Rebound hypertension after acute methyldopa withdrawal. Br Med J 1976; 1: 1056–7
  • Ram CV, Holland OB, Fairchild C, et al. Withdrawal syndrome following cessation of guanabenz therapy. J Clin Pharmacol 1979; 19: 148–50
  • O'Brien ET, MacKinnon J. Propranolol and polythiazide in treatment of hypertension. Br Heart J 1972; 34: 1042–4
  • Pederson OL. Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents. Eur J Clin Pharmacol 1976; 10: 381–5
  • Miller RR, Olson HG, Amsterdam EA, et al. Propranolol withdrawal rebound phenomenon: exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 1975; 293: 416–8
  • Shenkman L, Podrid P, Lowenstein J. Hyperthyroidism after propranolol withdrawal. JAMA 1977; 238: 237–9
  • Kristensen BO, Steiness E, Weeke J. Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clin Pharmacol Ther 1978; 23: 624–9
  • Jackson G, Schwartz J, Kates RE, et al. Physiologic basis for betablockade “rebound”: atenolol versus propranolol. Clin Res 1979; 27: 444A
  • Whelton PK, Flaherty JT, MacAllister NP, et al. Propranolol withdrawal in the pathogenesis of hypertension following coronary artery bypass surgery. Proc Int Soc Hypertension (Paris) 1978: 295
  • Dustan HP, Page IH, Tarazi RC, et al. Arterial pressure responses to discontinuing antihypertensive drugs. Circulation 1968; 37: 370–9
  • Mroczek WH, Davidov ME. Rebound hypertension after withdrawal of antihypertensive therapy. Clin Res 1978; 26: 622A
  • Keim HJ, Drayer JI, Case DB, et al. A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II). N Engl J Med 1976; 295: 1175–7
  • Dinon LR, Kim YS, Vander Veer JB. Clinical experience with chlorothiazide (Diuril) with particular emphasis on untoward responses: a report of 121 cases studied over a 15-month period. Am J Med Sci 1958; 236: 533–45
  • Shand DG. Propranolol withdrawal. (Editorial) N Engl J Med 1975; 293: 449–50
  • Diaz RG, Somberg JC, Freeman E, et al. Myocardial infarction after propranolol withdrawal. Am Heart J 1974; 88: 257–8
  • Frischman WH, Christodoulou J, Weksler B, et al. Abrupt propranolol withdrawal in angina pectoris: effects on platelet aggregation and exercise tolerance. Am Heart J 1978; 95: 169–79
  • Boudoulas H, Lewis RP, Kates RE, et al. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann Intern Med 1977; 87: 433–6
  • Nies AS, Aarons RD, Gal J, et al. Increased density of beta-adrenergic receptors on lymphocytes following propranolol treatment. Clin Res 1979; 27: 455A

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.